Peer review reports
From: Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
Original Submission | ||
---|---|---|
24 Nov 2016 | Submitted | Original manuscript |
18 Jan 2017 | Reviewed | Reviewer Report - Kristin Zorn |
1 Feb 2017 | Reviewed | Reviewer Report - Vijay Pandey |
9 Mar 2017 | Author responded | Author comments - Charles-André Philip |
Resubmission - Version 2 | ||
9 Mar 2017 | Submitted | Manuscript version 2 |
27 Jun 2017 | Author responded | Author comments - Charles-André Philip |
Resubmission - Version 3 | ||
27 Jun 2017 | Submitted | Manuscript version 3 |
25 Jul 2017 | Author responded | Author comments - Charles-André Philip |
Resubmission - Version 4 | ||
25 Jul 2017 | Submitted | Manuscript version 4 |
7 Aug 2017 | Author responded | Author comments - Charles-André Philip |
Resubmission - Version 5 | ||
7 Aug 2017 | Submitted | Manuscript version 5 |
28 Aug 2017 | Author responded | Author comments - Charles-André Philip |
Resubmission - Version 6 | ||
28 Aug 2017 | Submitted | Manuscript version 6 |
Publishing | ||
1 Sep 2017 | Editorially accepted | |
8 Sep 2017 | Article published | 10.1186/s12885-017-3639-0 |